SCHEMBL20008554

SCHEMBL20008554

CCOc1nnc(-c2cc(Nc3ccnc(C4CC4)c3)cnc2C)cc1N1CCCCC1

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.63
RAF1 P04049 19/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16103173 0.78 RAF1 (1.00) BRAFRAF1
SCHEMBL20009642 0.70 RAF1 (0.54) BRAFRAF1
SCHEMBL16103662 0.69 RAF1 (1.00) BRAFRAF1
SCHEMBL16099573 0.69 RAF1 (1.00) BRAFRAF1
SCHEMBL20009428 0.67 RAF1 (0.51) BRAFRAF1
SCHEMBL20008238 0.67 KMO (0.37) BRAFRAF1
SCHEMBL16095121 0.66 RAF1 (1.00) BRAFRAF1
SCHEMBL16094907 0.66 BRAF (0.75) BRAFRAF1
SCHEMBL16094755 0.66 BRAF (1.00) BRAFRAF1
SCHEMBL16095187 0.66 RAF1 (1.00) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3299367-A1 BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS Novartis AG (CH) 2018-03-28 EP disclosed